Effects of Simvastatin on serum monocyte chemoattractant protein-1,high sensitivity C-reactive protein in patients with acute coronary syndromes
Lists
Only you see this
Abstract
Objective:To investigate the effects of simvastation on serum monocyte chemoattractant protein-1 (MCP-1),high sensitivity C-reactive protein (hsCRP)in Patients with acute coronary syndromes.Methods:Serum MCP-1,hsCRP were detected by enzyme linked immunosorbent assay (ELISA)and turbidmetric 4 weeks before and after oral administration of simvastatin in 30 patients with ACS.Results:The contents of serum MCP-1,hsCRP in patients with ACS were significantly increased compared with health individuals (P0.01).A significant decreased serum MCP-1,hsCRP were observed 4 weeks after simvastatin-taken (P 0.01).Conclusion:The MCP-1 plays important roles in the prognosis in patients with ACS.Simvatatin has a beneficial on decreasing serum MCP-1,hsCRP and alleviating inflammatory reaction in patients with ACS.
BibTeX
@inproceedings{xie2009effects,
author = {Yutong Xie},
title = {{Effects of Simvastatin on serum monocyte chemoattractant protein-1,high sensitivity C-reactive protein in patients with acute coronary syndromes}},
booktitle = {China},
year = {2009},
}Loading related content...